Healthcare
Investing News
Market News
Technology
The Market Buzz
Plus Therapeutics Reports Share Repurchase Program
Plus Therapeutics, Inc. (NASDAQ: PSTV) has announced that its board of directors has approved a share repurchase program with authorization to repurchase up to USD 2 Million of the...